Do you reckon it's fair to say that it's the company's underlying mission of getting products commercialised and expedited to market that will set PTX apart from the crowd?
The statement by Steven about the PTX100 trials being a product play and not an academic one resonated with me. I get the impression that is their (or his) tactic to get products commercialised for two main reasons. To get therapies on the market to those who need it, namely the sufferers of cancer, and to make money to keep replicating that mission of fulfilling the former. That's what biotech and medical scince is all about... or should be! Big Pharma love acquiring little companies and their breakthrough technologies... and then quite literally shelving them. I reckon PTX is about to stick up the big pharma status quo. Dont you think?
Ptx to 10 bag by this time next year, page-10
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
-0.002(3.85%) |
Mkt cap ! $40.26M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 4.9¢ | $21.91K | 440.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 189208 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 6566 | 1 |
View Market Depth
| Last trade - 15.43pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.0¢ |
Change
-0.002 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 5.0¢ | 5.0¢ | 4.9¢ | 73482 | ||
| Last updated 15.59pm 01/05/2024 ? | |||||
| PTX (ASX) Chart |